RePS Study vs DoseRightCalc
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
RePS Study
This mobile program guides users through an eight-week self-help training to reduce posttraumatic stress symptoms. It involves daily engagement for 17 days, tracking behaviors, moods, and experiences, with follow-up measures administered through the app.
- Eight-week self-help training
- Daily behavior tracking
- Mood monitoring
- Experience logging
- Follow-up measures
Read full descriptionHide full description
RePS is a mobile self-help training program that aims to reduce posttraumatic stress symptoms. Over the course of eight weeks, participants are asked to engage with the mobile app daily for 17 days of training and tracking of behaviors, moods, and experiences and complete follow-up measures via the app.
DoseRightCalc
Calculate approximate THC dosage with an advanced bioavailability calculator for common consumption methods. Understand your body's absorption to promote responsible indulgence.
- THC dosage calculation
- Bioavailability calculator
- Supports common consumption methods
- Promotes responsible indulgence
- Free to use
Read full descriptionHide full description
Calculate approximate THC dosage with our advanced bioavailability calculator. Works for all common consumption methods. Do not guess what you intake, get to know what your body absorbs. The goal for this app to promote responsible indulgence. Free to use.
Screenshots
Verdict
The clearest difference is rating: DoseRightCalc at 5.0 against RePS Study's 1.7. DoseRightCalc also leads on update cadence (weekly vs every 3 months). RePS Study's advantage is ratings volume (13 vs 2) and iOS requirement (15.0 vs 18.2). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
DoseRightCalc holds the better App Store score, 5.0 against 1.7. That said, the two scores are not equally well evidenced: RePS Study has 13 ratings behind it against 2, so its average is the more settled of the two.
RePS Study ships an update every 3 months, DoseRightCalc weekly. The most recent releases landed on October 8, 2026 and October 14, 2026 respectively.
| Parameter | RePS Study | DoseRightCalc |
|---|---|---|
| Price | Free | Free |
| Rating | 1.7 (13 ratings) | 5.0 (2 ratings) — better |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 13 — better | 2 |
| Update frequency | Every 3 months | Weekly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPod | iPhone, iPad |
| Requires iOS | 15.0 — better | 18.2 |
| Further details — not scored | ||
| Size | 24 MB | 1 MB |
| Age rating | 12+ | 17+ |
| Developer | NEUROSCAPE ALLIANCE | Shankar Ramakrishnan |
Customer experience
RePS Study
DoseRightCalc
In-app purchases
RePS Study
No in-app purchases
DoseRightCalc
No in-app purchases
